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The coordinated regulation of mitochondrial and nuclear activities is essential for cellular 
respiration and its disruption leads to mitochondrial dysfunction, a hallmark of ageing
1-3
. 
Mitochondria communicate with nuclei via retrograde signalling pathways that modulate 
nuclear gene expression in order to maintain mitochondrial homeostasis
4-6
. The 
monooxygenase CLK-1 was previously reported to be exclusively mitochondrial, with a role 
in respiration and longevity
7,8
. We have uncovered a distinct nuclear form of CLK-1 that 
independently regulates lifespan. Nuclear CLK-1 mediates a novel retrograde signalling 
pathway that is conserved from Caenorhabditis elegans to humans and is responsive to 
mitochondrial reactive oxygen species, thus acting as a barometer of oxidative metabolism. 
We show that, through modulation of gene expression, the pathway regulates both 
mitochondrial ROS metabolism and the mitochondrial unfolded protein response. Our 
results demonstrate a novel nuclear role for a mitochondrial respiratory enzyme that 
controls longevity.   
 
Mitochondria function as cellular energy generators producing the fuel, predominantly in the 
form of adenosine triphosphate (ATP), required to drive biological processes. They act as a hub 
for many essential biochemical pathways, the metabolites of which are closely monitored by the 
cell9. The majority of the enzymes that are required for these pathways are encoded by the nuclear 
genome compared with a handful encoded directly by the mitochondrial genome. Therefore, 
coordinated regulation of nuclear and mitochondrial gene expression is essential10. Mitochondrial 
activity and dysfunction is monitored through a variety of mitochondrial readouts that activate or 
inhibit cytosolic signalling pathways, for example the rate of production of ATP or reactive 
oxygen species (ROS)2,4,11. These signalling pathways then ensure the appropriate changes in 
nuclear gene expression occur to maintain mitochondrial homeostasis.  
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The mitochondrial diiron containing monooxygenase CLK-1 catalyzes the hydroxylation of 5-
demethoxyubiquinone, a critical step in the biosynthesis of ubiquinone, an essential cofactor of 
the electron transport chain12,13. However, Caenorhabditis elegans clk-1 null mutants and 
heterozygous mice display altered mitochondrial metabolism and extended lifespans through a 
pathway that appears to be independent of ubiquinone biosynthesis14-16 indicating a separate 
function for CLK-1 may exist. 
 
CLK-1, and its human homologue COQ7, contain N-terminal mitochondrial targeting sequences 
(MTS)17,18 and are assumed to reside exclusively within mitochondria. However, we have 
observed nuclear pools of CLK-1 and COQ7 in C. elegans and cultured human cells, respectively. 
Endogenous and exogenously expressed COQ7 display both mitochondrial and nuclear 
immunostaining in HeLa cells (Figs. 1a, b and Supplementary Fig. 1a), while adult transgenic 
worms expressing CLK-1 fused to green fluorescent protein (GFP) display fluorescence in both 
compartments (Fig. 1c). We identified a sequence in COQ7 required for nuclear localisation 
(NTS), adjacent to the MTS, but within the N-terminal region that is cleaved and degraded by the 
mitochondrial processing peptidase (MPP) following mitochondrial import17,18 (Fig. 2b and 
Supplementary Fig. 1b). This suggested that a pool of COQ7, rather than being imported into 
mitochondria and cleaved, remains uncleaved and localises to the nucleus. This is supported by 
nuclear-specific immunostaining of endogenous COQ7 with antibodies that specifically recognise 
the N-terminal region (Fig. 1d and Supplementary Fig. 1c) and by the presence of both uncleaved 
and cleaved forms of COQ7 in cell lysates (Fig. 1g and Supplementary Figs. 1d-f). Taken 
together, these data establish that distinct mitochondrial and nuclear forms of CLK-1/COQ7 
coexist within cells.  
 
To address the functional significance of these two pools of CLK-1/COQ7, we explored whether 
its localisation could be regulated by mitochondrial activity. It has been proposed that the 
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regulation of mitochondrial protein import in response to changes in reactive oxygen species 
(ROS) production and peptide efflux can act as a gauge of mitochondrial activity and 
dysfunction5,19. We found that exposure of cells to an antioxidant (N-acetyl-L-cysteine; NAC) 
decreased the amount of nuclear COQ7, while the same treatment in worms reduced CLK-1-GFP 
nuclear localisation (Figs. 1e, f). Conversely, an increase in cellular or mitochondrial ROS 
enhanced nuclear COQ7 levels (Fig. 1g and Supplementary Fig. 2a). Interestingly, a mutant 
COQ7 with impaired mitochondrial targeting (COQ7 R11/14/16D) remained uncleaved and 
predominantly localised to nuclei, independently of ROS levels (Fig. 1h and Supplementary Figs. 
2b, c). These data are consistent with a model in which a distinct pool of CLK-1/COQ7 is 
targeted to the nucleus following inhibition of mitochondrial import through a ROS-dependent 
pathway.  
 
To further characterise the nuclear targeting of COQ7 we performed site-directed mutagenesis of 
conserved residues within the N-terminal NTS and identified a point mutant (R28A) that, 
compared to wild type COQ7, displayed significantly reduced nuclear localisation (Fig. 2a and 
Supplementary Figs. 3a, b). Furthermore, by inserting an epitope-tag (OLLAS) immediately C-
terminal to the NTS but prior to the MPP cleavage site, we could demonstrate that uncleaved wild 
type COQ7 is present in nuclei but we could not detect any uncleaved R28A mutant (Fig. 2b, c). 
This is supported by immunoblots of cell lysates showing decreased amounts of uncleaved R28A 
mutant protein (Supplementary Fig. 2c). These data suggest that a pool of wild type COQ7 can be 
redirected to the nucleus before mitochondrial import but the R28A mutant cannot be and is 
therefore predominantly targeted to mitochondria where it is cleaved.  
 
Since the loss of COQ7 expression would affect both its mitochondrial and nuclear functions, we 
created a system to specifically determine the effect of depleting nuclear COQ7. Cell lines were 
established with endogenous COQ7 expression replaced by ectopic expression of either wild type 
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COQ7 or the non-nuclear R28A mutant (Fig. 2d and Supplementary Fig. 3d). As expected, the 
uncleaved wild type COQ7 resided in the nuclear fraction but this form was absent in the R28A 
expressing cells (Fig. 2e). Importantly, both cell lines had normal levels of ubiquinone (Fig. 2f 
and Supplementary Fig. 3e). However, loss of nuclear COQ7 resulted in a decreased cell count 
that, in the absence of an increase in cell death, was indicative of impaired proliferation (Fig. 2g 
and Supplementary Fig. 3f). These data demonstrate that COQ7 has a biologically relevant 
nuclear role that is independent of its characterised mitochondrial biosynthetic function.  
 
The N-termini of C. elegans CLK-1 and human COQ7 are not well conserved compared to the 
diiron-binding domain C-terminal to their predicted MPP cleavage sites (Supplementary Fig. 4a). 
Indeed, the N-terminal residues we identified as being critical for nuclear localisation of COQ7 
do not appear to be conserved in CLK-1. However, both homologues localise to the nucleus in a 
ROS-dependent manner (Fig. 1) suggesting that their nuclear role is conserved but the precise 
molecular mechanism by which they are targeted to the nucleus is not. To address the non-
mitochondrial role of worm CLK-1, we generated a GFP-tagged CLK-1 construct in which the 
predicted thirteen residue MTS, prior to the MPP site, was deleted. Transgenic worms expressing 
this protein showed it localised predominantly to the nucleus demonstrating that, similar to 
COQ7, when mitochondrial targeting is impaired nuclear localisation is prevalent (Fig. 3a). We 
next crossed transgenic worms expressing either full length CLK-1 (clk-1wt) or the truncated 
nuclear-only form of CLK-1 (clk-1nuc(+)) with the clk-1 null worm qm30 (clk-1(-)). As expected, 
full length CLK-1 was able to rescue ubiquinone biosynthesis in these worms, however, CLK-
1nuc(+) could not. This infers that, similar to nuclear COQ7 in human cells, nuclear CLK-1 does 
not contribute to the mitochondrial biosynthetic role of CLK-1 in worms (Supplementary Fig. 
4b).  
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We next analysed our two complementary models, nuclear only CLK-1 in worms and 
mitochondrial only COQ7 in human cells, for changes in ROS responses, a phenotype of clk-1 
null worms20. Expression of CLK-1nuc(+) in clk-1 null worms partially rescued the increased ROS 
levels observed in these animals (Fig. 3b and Supplementary Fig. 4c). Importantly, we also 
observed increased basal and induced levels of ROS in human cells lacking nuclear COQ7 (Fig. 
3d), suggesting nuclear CLK-1/COQ7 plays a conserved role in maintaining low levels of ROS. 
CLK-1nuc(+) was also able to significantly rescue the ROS-sensitivity phenotype of clk-1 null 
worms when exposed to the mitochondrial respiratory chain inhibitor paraquat (Fig. 3c), whereas 
human cells expressing mitochondrial only COQ7 (R28A) were sensitive to ROS-induced cell 
death (Figs. 3e). These results indicate that there is a conserved role for nuclear CLK-1/COQ7 in 
the response of cells to ROS, potentially through regulation of ROS metabolism.  
 
Mitochondrial glutamate metabolism is a key regulator of cellular redox balance and its inhibition 
is linked to increased ROS levels in cancer cells21. We examined whether the expression of the 
mitochondrial form of glutaminase (GLNA-1 in worms/GLS2 in humans) was regulated in a 
nuclear CLK-1/COQ7-dependent manner. In clk-1 null worms, glna-1 transcript levels were 
decreased compared to wild type animals, an effect that was rescued in the presence of CLK-
1nuc(+) (Fig. 3f and Supplementary Fig. 4d). Loss of nuclear COQ7 in human cells also resulted in 
a decrease in expression of the glna-1 homologue GLS2 (Figs. 3h, j and Supplementary Fig. 4g), 
suggesting that nuclear CLK-1/COQ7 may regulate cellular ROS levels by modulating glutamate 
metabolism. Another regulator of ROS metabolism is the oxidoreductase WWOX, a 
hyperactivated form of which has been shown to increase cellular ROS levels in Drosophila 
melanogaster
22. Furthermore, the transcript levels of one of the worm WWOX homologues are 
increased in clk-1 null worms23. Intriguingly, we found that expression of CLK-1nuc(+) could 
rescue the increased expression of the closest WWOX homologue, dhs-7, in clk-1(-) worms, and 
that human WWOX expression was increased upon loss of nuclear COQ7 (Figs. 3g, h, j, and 
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Supplementary Figs. 4d, g). Taken together these data suggest nuclear CLK-1/COQ7 can 
potentially regulate metabolic pathways that alter cellular ROS production independently of 
ubiquinone.  
 
Since cellular ROS levels were changed in a nuclear CLK-1/COQ7-dependent manner we sought 
to determine whether ROS-dependent gene expression was also altered. We found that transcripts 
of sod-2, encoding a ROS detoxification enzyme, were increased in clk-1 null worms as 
previously reported24, while transcripts of skn-1, encoding a transcription factor that is a central 
regulator of ROS homeostatic gene expression25, were also increased (Supplementary Fig. 4e). 
The expression of nuclear CLK-1 in clk-1 null worms abrogated the increased transcript levels of 
these genes (Supplementary Fig. 4e). Homologues of these genes, SOD2 and NRF2, and the 
NRF2 target gene HMOX1 were also increased in human cells lacking nuclear COQ7 (Fig. 3j and 
Supplementary Fig. 4f) suggesting that the altered ROS phenotype activates a ROS-defensive 
gene expression program. However, as the loss of nuclear CLK-1/COQ7 sensitises cells to 
oxidative stress (Fig. 3c and e) even in the presence of these increased ROS defenses, it suggests 
that survival pathways may also be altered. To address this we looked at the expression of the 
proapoptotic mitochondrial protease HTRA2, which is stimulated through a ROS-dependent 
retrograde pathway activated by disruption to mitochondrial proteostasis26.  HTRA2 levels were 
significantly increased in cells lacking nuclear COQ7 (Figs. 3i, j and Supplementary Fig. 4g) and 
inhibition of HTRA2 activity rescued the ROS-sensitivity phenotype of these cells (Fig. 3k). 
These data further support a role for nuclear CLK-1/COQ7 in regulating retrograde ROS 
responses through modulation of gene expression.   
 
In addition to changes in ROS metabolism, C. elegans clk-1 null mutants and heterozygous mice 
have extended lifespans7,16. C. elegans lacking CLK-1 survive by obtaining ubiquinone from their 
diet while heterozygous clk-1 mice display wild type ubiquinone levels, suggesting that their 
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increased longevity may be unrelated to CLK-1’s function in ubiquinone biosynthesis14,16. 
Remarkably, expression of CLK-1nuc(+) in clk-1 null worms caused a decrease in their enhanced 
longevity phenotype (Figs. 4a, b and Supplementary Table 1). This infers that nuclear CLK-1 can 
regulate longevity and that this is not related to the role of CLK-1 in mitochondrial ubiquinone 
biosynthesis. Interestingly, the expression of CLK-1nuc(+) did not rescue the delayed larval 
development observed in clk-1 null worms7 (Supplementary Fig. 5a), which is consistent with this 
phenotype being due to the loss of mitochondrial CLK-1.   
 
The extended lifespans of clk-1 mutants, and other mitochondrial longevity phenotypes, has been 
linked to activation of a distinct mitochondrial to nuclear retrograde pathway, the mitochondrial 
unfolded protein response (UPRmt)5,6. The UPRmt responds to mitochondrial dysfunction by 
regulating nuclear gene expression27 and there is an increase in the expression of some UPRmt-
responsive genes in clk-1 null worms5,23. Thus, it is plausible that there could be crosstalk 
between CLK-1 nuclear signaling and the UPRmt. Indeed, we found that the expression of an 
UPRmt-responsive fluorescent reporter, which is activated in clk-1 null worms, was significantly 
reduced in the presence of CLK-1nuc(+) (Fig. 4c), indicating that nuclear CLK-1 may potentially 
act as a suppressor of the UPRmt. We subsequently monitored transcript levels for a range of 
UPRmt genes5,28 and identified a subset (hsp-6, hsp-60, spg-7) where increased expression in clk-1 
null worms was abrogated by expression of CLK-1nuc(+) (Fig. 4d and Supplementary Fig. 5b). 
Importantly, this regulation of the UPRmt was conserved as the suppressed expression of 
homologues of these genes (HSPD1, HSPA9, AFG3L2) and of other UPRmt-associated genes 
(ATG16L1, CLPP, LONP1, SPG7, TIMM22) was relieved upon loss of nuclear COQ7 in human 
cells  (Figs. 4e, f and Supplementary Fig. 5c). The UPRmt can be activated by an imbalance 
between mitochondrial and nuclear encoded mitochondrial proteins6, but this was not observed in 
cells lacking nuclear COQ7 (Fig. 4f and Supplementary Fig. 5d; compare MTCO1 with COXIV). 
Furthermore, we noted that some of the UPRmt-associated genes not regulated by nuclear CLK-
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1/COQ7 (DNAJA3, PMPCB, ymel-1/YME1L1, ENDOG, tim-17) are downstream targets of a 
distinct UPRmt instigated in the mitochondrial matrix28 (Figs. 4d, e and Supplementary Figs. 5b, 
c). These data, therefore, indicate that nuclear CLK-1/COQ7 selectively suppresses a specific 
branch of the UPRmt. 
 
Since nuclear CLK-1/COQ7 appears to have a role in regulating gene expression, this could be 
through direct association with chromatin and components of the gene expression machinery or 
through an indirect intra-nuclear pathway. To address this we performed chromatin fractionation 
of cells expressing COQ7 or the non-nuclear R28A mutant, both featuring an OLLAS tag inserted 
in the N-terminus just prior to the MPP cleavage site to allow specific detection of the uncleaved 
protein (Fig. 2b). The uncleaved form of COQ7, but not the R28A mutant, was enriched in the 
chromatin fraction suggesting it does associate directly with DNA-protein complexes (Fig. 5a). 
We next performed chromatin immunoprecipitation (ChIP) for endogenous COQ7 followed by 
promoter microarray (ChIP-on-chip) analysis (Supplementary Fig. 5e). We identified a number of 
unique promoter sites enriched in COQ7 ChIPs compared with the IgG control (Supplementary 
Table 2). Interestingly, two genes whose expression is regulated by nuclear CLK-1/COQ7, 
WWOX and TIMM22, had sites that were enriched in the COQ7 ChIP (Fig. 5b). To confirm these 
were genuine COQ7 chromatin-bound sites, we performed ChIP followed by qPCR targeting 
these sites and demonstrated that wild type COQ7 expressing cells displayed an enhanced ChIP 
signal compared to cells expressing the non-nuclear R28A mutant (Fig. 5c). Importantly, we also 
showed that ChIP signals for endogenous COQ7 at the WWOX and TIMM22 sites were decreased 
following treatment with the antioxidant NAC (Fig. 5d), which would correlate with the decrease 
in amount of nuclear COQ7 observed under such conditions (Fig. 1f). These data establish that 
the nuclear pool of COQ7 can associate directly with chromatin and that this may contribute to its 
ability to regulate gene expression.  
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Intriguingly, we did not detect COQ7 chromatin binding sites on the promoters of all the genes 
that we have found to be potentially regulated by nuclear COQ7 (although these could reside 
outside of the core promoter regions covered by the array) and, while we have demonstrated that 
nuclear COQ7/CLK-1 can suppress WWOX and TIMM22 expression (Figs. 3g, h and 4e), we also 
have evidence that it positively regulates transcription (e.g. GLS2/glna-1; Figs. 3f and h). 
Therefore, while our current data point to COQ7 directly regulating transcription by associating 
with chromatin, it will be interesting in future studies to determine the precise mechanisms by 
which it positively or negatively impacts on gene expression.  
 
In summary, we have discovered a conserved role for the respiratory enzyme CLK-1/COQ7 as a 
direct mediator of mitochondrial to nuclear retrograde signaling that responds to changes in 
cellular oxidative status and regulates mitochondrial ROS metabolism and proteostasis. The 
nuclear pool of CLK-1/COQ7 can associate with distinct regions of chromatin and affect gene 
expression. CLK-1 was previously assumed to modulate lifespan solely by acting in 
mitochondria, but we have now established that a nuclear form acts independently to inhibit 
longevity. CLK-1 null worms have defective oxidative phosphorylation29 and, similar to the many 
other respiration mutants that are long-lived30, this is likely to contribute to their increased 
lifespan. This suggests that the mitochondrial and nuclear forms of CLK-1 contribute to lifespan 
phenotypes through distinct mechanisms (Fig. 5e and Supplementary Fig. 6).  
  
Previously, elevation of ROS signaling and activation of the UPRmt were reported to promote 
longevity6,20,31-33, thus the modulation of these pathways by nuclear CLK-1/COQ7 would be 
consistent with its role in limiting lifespan. Our data suggests that nuclear CLK-1/COQ7 
functions as a rheostat to maintain ROS homeostasis and dampen stress-responsive pathways such 
as the UPRmt. In such a model, basal levels of ROS, produced by mitochondria during normal 
functioning, direct a pool of CLK-1/COQ7 to the nucleus where it regulates gene expression. 
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Some CLK-1/COQ7-regulated genes are directly involved in mitochondrial ROS metabolism and 
therefore, the prolonged presence of CLK-1/COQ7 in the nucleus instigates a decrease in ROS 
production to suboptimal levels. Reduced ROS leads to CLK-1/COQ7 being predominantly 
localised to mitochondria, and not the nucleus, so its affects on gene expression are relieved, basal 
ROS production returns, and homeostasis is maintained. Under these conditions, nuclear CLK-
1/COQ7 partially suppresses the UPRmt suggesting that it acts to prevent activation of this 
pathway during non-stress conditions. Upon mitochondrial dysfunction that results in enhanced 
levels of ROS, the pool of nuclear CLK-1/COQ7 increases and protects against the ROS stress 
but limits hyperactivation of the UPRmt. While the UPRmt offers protection following the 
accumulation of unfolded or misfolded proteins in mitochondria, it is not clear whether it plays a 
significant role in the cellular response to oxidative stress. Indeed, it has previously been reported 
that activation of the UPRmt does not confer resistance to worms subjected to high levels of a 
mitochondrial ROS stress5. 
 
This work represents the first example of a mitochondrial respiratory enzyme where two distinct 
forms from the same translation product are targeted to separate organelles, with the 
mitochondrial form participating in oxidative phosphorylation and the nuclear form acting as a 
sensor of metabolic activity through regulating gene expression. In worms, the transcription factor 
ATFS-1 also localises to both organelles but, unlike CLK-1, only translocates to the nucleus 
during times of mitochondrial stress when normal proteostasis is disrupted, usually being 
degraded following mitochondrial import5. It will be of interest to determine if redirection from 
mitochondria to nuclei represents a paradigm for other proteins in maintaining homeostasis during 
mitochondrial activity or dysfunction. This study contributes to our understanding of the 
fundamental signalling processes that mediate the response of cells and organisms to changes in 
respiratory activity that occur during ageing and in disease.  
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Methods 
Plasmids and molecular cloning. 
pcDNA3.1-COQ7, pcDNA3.1-COQ7(37-217), pcDNA3.1-COQ7-3xMyc (C-terminal 3xMyc 
tag), pEGFP-N1-COQ7 (C-terminal GFP tag), pEGFP-C2-COQ7 (N-terminal GFP tag), pEGFP-
C2-COQ7(11-217) (N-terminal GFP tag), pEGFP-C2-COQ7(30-217) (N-terminal GFP tag), and 
pGEX6P1-COQ7 (N-terminal GST tag) were cloned by PCR amplification followed by 
restriction digest and ligation into the respective parent plasmid. pcDNA3.1-COQ7(R28A), 
pcDNA3.1-COQ7(S36A), pcDNA3.1-COQ7(R11/14/16D)-3xMyc (C-terminal 3xMyc tag), 
pEGFP-N1-COQ7(R21A) (C-terminal GFP tag), pEGFP-N1-COQ7(Y26F) (C-terminal GFP tag), 
pEGFP-N1-COQ7(R28A) (C-terminal GFP tag), pcDNA3.1(CM) (CMV minimal promoter -58 
to +63), pcDNA3.1(CM)-COQ7-OLLAS (sequence encoding OLLAS tag 
(SGFANELGPRLMGKR) inserted between amino acids 33 and 34), pcDNA3.1(CM)-COQ7-
OLLAS/FLAG (sequence encoding OLLAS tag inserted between amino acids 33 and 34 and C-
terminal FLAG tag), pcDNA3.1(CM)-COQ7(R28A)-OLLAS/FLAG (sequence encoding OLLAS 
tag inserted between amino acids 33 and 34 and C-terminal FLAG tag), and pcDNA3.1(CM)-
COQ7(R11/14/16D)-3xMyc (C-terminal 3xMyc tag) were generated with QuikChange Lightning 
site directed mutagenesis kit (Agilent Technologies). Primer sequences for cloning/mutagenesis 
available on request.  
 
siRNA. 
Knock down of endogenous COQ7 transcripts was performed using a pool of siRNA against- 5’-
UTR: 5’-AGCAACCACUUCGUUGAACUU-3’ and 5’-ACUUCGUUGAACGGAACUGUU-3’; 
and 3’-UTR: 5’-ACCUGUUUCUCUGCAAAUGUU-3’. 
 
Cell culture, transfections and stable cell lines. 
HeLa, COS7, and HEK293 cells were obtained from ATCC and maintained in Dulbecco’s 
modified Eagle’s medium supplemented with 5 mM glutamine, 100 units/ml 
penicillin/streptomycin, and 10% fetal bovine serum (Life Technologies). Plasmid DNA 
transfections were performed with jetPEI (Polyplus) and siRNA transfections with Lipofectamine 
RNAiMAX (Life Technologies). HEK293 stable cell lines were selected with 1 mg/ml G418 
(Sigma) following transfection with pcDNA3.1-COQ7 or pcDNA3.1-COQ7(R28A), before 
monoclonal isolation and expansion. Hydrogen peroxide (Sigma), tert-butyl hydroperoxide 
(Luperox TBH70X, Sigma), and cobalt (II) chloride hexahydrate (Sigma) were diluted in water 
before use; HTRA2 inhibitor, UCF-101 (Calbiochem) was re-suspended in DMSO.  
! ∀∃!
 
Antibody generation and purification. 
COQ7 antibodies were raised in rabbit using bacterially expressed GST-COQ7 as an immunogen. 
Rabbits were immunised and serum harvested off-site (Genscript, USA) and were purified against 
the N-terminus, essentially as described34. Briefly, bacterially expressed GST or GST-COQ7(1-
37) bound to GSH-sepharose were washed twice in 0.2 M borate pH 8.6 before incubation in 20 
mM dimethyl pimelimidate in 0.2 M triethanolamine pH 8.3 for 30 minutes to crosslink the 
proteins to the resin. Crosslinking was terminated by addition of 0.2 M ethanolamine pH 8.2 for 1 
h before two washes in 0.1 M glycine pH 2.5 to remove non-covalently linked molecules before 
equilibration in TBS (15 mM Tris-HCl pH 7.4, 150 mM NaCl). Antibodies to be purified were 
adjusted to 1x TBS before incubation with GSH-GST cross-linked resin for 4 h and GST-specific 
antibodies removed by centrifugation. The supernatant was added to GSH-GST-COQ7(1-37) 
cross-linked resin, incubated for 18 h and washed. COQ7(1-37)-specific antibodies (COQ7N-term2) 
were eluted with 0.1 M glycine pH 2.5 before pH adjustment to neutral with 2 M Tris.  COQN-term 
anti-COQ7(1-37)-specific antibodies were derived using the same protocol but starting with anti-
COQ7 (Santa Cruz, sc-135040). For COQ72 antibodies GST cleared supernatants were incubated 
with GSH-GST-COQ7 (full length) before glycine elution.  
 
Antibodies. 
The following antibodies were used for protein identification: anti-c-Jun (JUN, Santa Cruz, sc-
1694); anti-CLPP (Santa Cruz, sc-134496); anti-COQ7 (Proteintech, 15083-1-AP); anti-COXIV 
(Pierce, MA5-15078); anti-FLAG (M2, Sigma, F1804); anti-GLS2 (Abcam, ab113509); anti-GST 
(GE Healthcare, 27-4577-01); anti-HSPA9 (Grp75/mtHsp70, Cell Signaling, 2816S); anti-HSPD1 
(HSP60, BD Transduction Laboratories, 611562); anti-HTRA2 (OMI, Biovision, 3497-100); anti-
Lamin B1 (LMNB1, Santa Cruz, sc-6216); anti-MTCO1 (1D6E1A8, Life Technologies, 459600); 
anti-Myc (4A6, Millipore, 05-742); anti-NRF2 (NFE2L2, Santa Cruz, sc-722); anti-WWOX (Cell 
Signaling, 4045); anti-OLLAS (Novus Biologicals, NBP1-06713 and Genscript, A01658); anti-
Tubulin β (TUBB, Abcam, ab6046); anti-VDAC (Cell Signalling, 4866).  
 
Immunofluorescence, microscopy and image analysis. 
Cells for microscopy were grown on coverslips, fixed in 4% paraformaldehyde (PFA, Sigma) for 
10 minutes then permeabilized in 0.2% Triton X-100 for 10 minutes. All steps were performed in 
1x PBS (phosphate buffered saline, Fisher). For immunofluorescence, cells were blocked in 3% 
bovine serum albumin (BSA) for 1 h, incubated in primary antibody in 3% BSA for 18 h, washed, 
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incubated in Alexa Fluor conjugated secondary antibody (Life Technologies) in 3% BSA for 1 h, 
and washed again. Coverslips were mounted in ProLong Gold with DAPI (Life Technologies). 
For MitoTracker (MitoTracker Red CMXRos; Life Technologies) staining, the dye was applied at 
10 µM to media 30 minutes before cell fixation. For endogenous COQ7 immunofluorescence, 
cells were fixed in PFA for 5 minutes and permeabilized in methanol at 20°C for 2 minutes, then 
0.2% Triton X-100 for 5 minutes. Images were collected on an Olympus BX51 upright 
microscope using a 60x objective and captured using a Coolsnap ES camera (Photometrics) 
through MetaVue software (Molecular Devices). Images were processed and analysed using 
Adobe Photoshop and ImageJ. Images shown in Figures 1a, b, d, h, 2a, c, and Supplementary 
Figures 1b and c are representative of 3 independent experiments.  
 
Western blotting. 
Western blotting was performed essentially as described35. Briefly, cell lysates, unless for 
fractionations, were prepared in Triton lysis buffer (TLB: 20 mM Tris-HCl pH 7.4, 150 mM 
NaCl, 25 mM β-glycerophosphate, 2 mM sodium pyrophosphate, 2 mM EDTA, 1% Triton X-
100, 10% glycerol plus protease inhibitors). Samples were resolved by SDS-PAGE (10-13% gels) 
and transferred to Immobilon-P membranes (Millipore), which were then immunoblotted. 
Primary antibodies were detected with IRDye 800CW or IRDye 680LT secondary antibodies (LI-
COR) using the Odyssey imaging system or HRP-conjugated secondary antibodies (Amersham 
Biosciences), followed by enhanced chemiluminescence (Pierce). Densitometry was performed 
using ImageJ.  
 
Mitochondrial Isolation. 
Mitochondrial isolation was performed essentially as described36. Briefly, cell pellets were re-
suspended in hypotonic buffer (10 mM Tris-HCl pH 7.4, 0.1 mM EDTA, 250 mM sucrose) and 
left on ice to swell for 10 minutes. Cells were homogenized on ice with 50 strokes of a Dounce 
Homogenizer before centrifugation at 500 g for 5 minutes to pellet the nuclear fraction. The 
supernatant was transferred to a new tube and centrifuged again at 10, 000 g for 20 minutes to 
pellet mitochondria.  
 
Cell survival, death and proliferation assays. 
Cell survival was measured by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide, Sigma) assay. 5 mg/ml MTT was added to cells 4 h before experimental end points after 
which cells were washed and intracellular formazan (reduced MTT) solvated with 0.4 M HCl in 
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99% propanol for 1 h. The amount of formazan was assayed using a microplate reader 
spectrophotometer at A570 nm. Cell death was measured by lactose dehydrogenase presence in 
media, released from apoptotic or necrotic cells, using the CytoTox 96 Non-Radioactive 
Cytotoxicity Assay (Promega), following the manufacturer’s instructions. Proliferation was based 
on MTT activity in the absence of detectable cell death.  
Cellular ROS measurements.  
Intracellular ROS levels were determined by incubating cells with 10 µM 2',7'-dichlorofluorescein 
diacetate (DCFDA, Life Technologies) for 30 minutes before which cells were washed, lysed in 
TLB and centrifuged at 20, 000 g for 10 minutes. DCF fluorescence was measured in triplicate 
from supernatants using a microplate reader spectrophotometer at excitation 485 nm and emission 
520 nm.   
 
RNA isolation and quantitative reverse transcription PCR. 
RNA was isolated from cells using the RNeasy system (Qiagen) following the manufacturer’s 
instructions. Contaminating DNA was removed using the DNA-free Kit (Life Technologies). 
Quantitative reverse transcription PCR analysis was performed for both HEK293 cells and worm 
samples using Power SYBR Green RNA-to-CT 1-Step Kit (Life Technologies) following 
manufacturer’s instructions, with 10 µl reactions. Each experimental repeat was run in triplicate. 
Primer sequences can be found in Supplementary Table 3. References for primer sequences 
available on request. Reference genes for quantification: human, RPL19; C. elegans, act-1 and 
tba-1. Changes in gene expression were quantitated using the ∆∆Ct method37, normalizing for 
each gene to the reference gene for the same sample and then to one control sample, as indicated 
in figure legends. The heat map was generated using Multi Experiment Viewer software and 
represents the mean values of four independent experimental repeats.  
 
Quinone extraction and reverse phase high performance liquid chromatography. 
Quinone extraction and determination was essentially as describe38. Briefly, cell or worms pellets 
that had been frozen and thawed three times were re-suspended in lysis buffer (15 mM Tris-HCl 
pH 7.4, 150 mM NaCl, 0.1% SDS) and vortexed. Quinones were extracted by vortexing re-
suspended pellets in ethanol/hexane (2/5, v/v) for 10 minutes followed by centrifugation at 20, 
000 g for 5 minutes and the top hexane supernatant layer removed. This was repeated three times 
and supernatants combined. Hexane was removed by drying in a SpeedVac Concentrator and the 
residue re-suspended in ethanol. Re-suspended quinones were applied to a reverse-phase column 
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(Jupiter 4 µm Proteo 90 Å, C-12, 250 x 4.6 mm, Phenomenex) and eluted in isocratic condition (1 
ml/minute, diisopropyl ether/methanol (1/4, v/v)) by high-performance liquid chromatography 
(Ettan LC, GE Healthcare). Eluted quinones were compared using their retention times and UV 
spectrophotometry (A275 nm). Ubiquinone-10 (Coenzyme Q10, Sigma) and ubiquinone-9 
(Sigma) were used as standards for human and C. elegans endogenous ubiquinone, respectively. 
Clioquinol (Vetranal, Sigma) was used to inhibit COQ7 activity39 leading to accumulation of its 
substrate demethoxyubiquinone-10. Chromatograms in Figures 2g, 3c and Supplementary Figures 
2f, 3a are representative of 3 independent experiments. 
 
Chromatin fractionation. 
Isolation of chromatin/DNA-associated protein complexes from cells was performed as 
described40. Briefly, cells were washed then scraped in CSK buffer (10 mM PIPES pH 6.8, 300 
mM sucrose, 100 mM NaCl, 3 mM magnesium chloride, 1 mM EGTA, 0.5% Triton-X-100 plus 
protease inhibitors) and left at 4°C for 5 minutes before centrifugation at 5000 g for 3 minutes. 
The supernatant was removed as the triton-soluble fraction (TS). The pellet was resuspended in 
CSK buffer containing 30 U DNase I (New England Biolabs) and incubated at 37°C for 20 
minutes followed by precipitation of chromatin by addition of 0.25 M ammonium sulphate and 
incubation at 4°C for 5 minutes. Samples were then centrifuged at 5000 g for 3 minutes and the 
supernatant taken as the DNase –soluble fraction (DS).  
 
Chromatin immunoprecipitation. 
Chromatin immunoprecipitations (ChIPs) for qPCR analysis of promoter regions or promoter 
microarray were carried out as follows41. Cells were washed then crosslinked in 0.85% 
formaldehyde for 10 minutes at 20°C before quenching with a final concentration of 0.125 M 
glycine for 5 minutes. Cells were then washed and lysed in FA buffer (50 mM Tris pH 8, 150 mM 
NaCl, 1 mM EDTA, 1% Triton-X-100, 0.1% sodium deoxycholate, 0.1% SDS, protease 
inhibitors) for 10 minutes at 4°C followed by sonication using a 4°C water bath sonicator 
(Bioruptor Sonicator, Diagenode) set to medium power with cycles of 30 seconds on 30 seconds 
off for 5 minutes or until average DNA fragment length of 0.3-0.7 kb was obtained. Samples were 
centrifuged at 21000 g for 10 minutes before addition of ABRI buffer (50 mM Tris pH 8, 150 
mM NaCl, 1 mM EDTA, 0.5% NP-40, 0.5% sodium deoxycholate, protease inhibitors) 3:1 to 
supernatants. 1/20 of each sample was taken as input and the rest used for IPs. 2 µg of each 
antibody (COQ72 or rabbit IgG control, Santa Cruz, sc-2027) was added before rotation for 18 
hours at 4°C before addition of 15 µl prewashed protein A Dynabeads (Life Technologies) for a 
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further 1 hour. ChIPed complexes were washed once in ABRI buffer, twice in WB1 buffer (20 
mM Tris pH 8, 2 mM EDTA, 150 mM NaCl, 1% Triton-X-100), twice in WB2 buffer (20 mM 
Tris pH 8, 2 mM EDTA, 250 mM LiCl, 0.5% NP-40, 0.5% sodium deoxycholate), and once in 
TE buffer (25 mM Tris, 1 mM EDTA) before elution in 1% SDS and 0.1 M NaCHO3 with 
rotation/shaking at 30°C for 30 minutes. Eluted complexes and inputs were then adjusted to 150 
mM NaCl and crosslinks reversed by incubation at 65°C for 18 hours. Samples were then treated 
with proteinase K (Sigma) for 2 hours at 50°C. ChIPed and input DNA was then 
phenol/chloroform/IAA (Sigma) purified and washed before final solvation in TE buffer. 
 
For qPCR analysis of promoter enrichment primers against regions (Supplementary Table 3) of 
interest were used to amplify DNA in both ChIPs and inputs and antibody enrichment calculated 
as a percent of input using the following formulae: 2X = input dilution factor, total input Ct value 
= input Ct – X, sample % input = 2(total input Ct- sample Ct) x 100.  
 
For promoter microarray analysis, DNA samples for IgG control or COQ7 ChIPs were amplified 
using random primer PCR amplification. DNA was subjected to two rounds of PCR, initially 
reactions of 40 ng DNA, 1x Sequenase buffer (US Biochemical) and 5 µM of the degenerate 
primer 5’-GTTTCCCAGTCACGATCNNNNNNNNN-3’ were subjected to two cycles of primer 
extension: 98°C for 5 minutes, 8°C for 4 minutes, slow ramped (10%) from 8°C to 37°C before a 
further 8 minutes at 37°C. During the first 8°C hold the reaction mixture was adjusted to 0.25 mM 
dNTPs, 3 mM DTT and 0.05 mg/ml BSA; during the second 8°C hold 1.5 U/µl Sequenase (US 
Biochemical) was added. DNA was purified with a PCR Cleanup Kit (Qiagen) and all eluted 
DNA was then subjected to a second round of PCR with 1 U/µl Biotaq polymerase (Gentaur), 
0.25 mM dNTPs, 1x Biotaq buffer and 1 µM of the amplification primer 5’-
GTTTCCCAGTCACGATC-3’ denatured at 97°C for 3 minutes before 25 cycles of: 97°C for 30 
seconds, 40°C for 10 seconds, 50°C for 30 seconds and 72°C for 90 seconds; followed by a final 
extension of 72°C for 5 minutes. Amplified DNA was again purified as before and 10 µg of each 
sample sent for processing at the on-site genomic technologies facility. Enriched probe sets were 
analysed for two repeats of the experiment and regions significantly enriched in COQ7 ChIPs 
compared to IgG control are listed in Supplementary Table 2.  
 
C. elegans strains. 
C. elegans were cultured at 20oC on nematode growth medium (NGM) agar plates spotted with 
OP50 strain Escherichia Coli42. Strains used were wild type Bristol N2, MQ130 clk-1 
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(qm30), SJ4100 (zcIs13 [hsp-6::gfp]) and EG6699 ttTi5605; unc-119 (ed3); oxEx1578. 
Transgenic strains made in this study were OL0092 ukSi1[pclk-1::clk-1::gfp, cb-unc-
119(+)], OL0119 ukSi2[pclk-1::clk-1 ∆MTS (13-187)::gfp, cb-unc-119(+)], OL0100 ukSi1[pclk-
1::clk-1::gfp, cb-unc-119(+)]; clk-1 (qm30), OL0177 ukSi1[pclk-1::clk-1::gfp, cb-unc-119(+)]; 
stIs10116[phis-72::his-24::mcherry::let-858 3’ UTR], OL0120 ukSi2[pclk-1::clk-1 ∆MTS (13-
187)::gfp, cb-unc-119(+)]; clk-1 (qm30), OL0121 clk-1 (qm30); hsp-6::gfp and OL0123 
ukSi2[pclk-1::clk-1 ∆MTS (13-187)::gfp, cb-unc-119(+)]; clk-1 (qm30); hsp-6::gfp. 
 
Generation of C. elegans transgenic strains. 
Transgenic strains OL0092 and OL0119, were generated using MosI mediated single copy 
insertion (MosSCI) as described previously43. Briefly, a plasmid containing pclk-1::clk-1::gfp was 
generated using Gateway techniques (Invitrogen). pDONR clones were generated for the clk-1 
promoter and open reading frame using Gateway and gene-specific primers. The vector pJA25644 
was used as the pDONR clone for GFP. The final destination vector used was pCFJ150, which 
contains an unc-119 rescue fragment. pclk-1::clk-1 ∆MTS (13-187)::gfp was generated by 
mutagenesis of the pclk-1::clk-1::gfp plasmid. Primer sequences are available on request. MosSCI 
was performed using the direct injection protocol. unc-119 animals were injected with an injection 
mix consisting of: pCFJ150 containing pclk-1::clk-1::gfp or pclk-1::clk-1 ∆MTS (13-187)::gfp (50 
ng/µl), pCFJ601 (50 ng/µl), pMA122 (10 ng/µl), pGH8 (10 ng/µl), pCFJ90 (2.5 ng/µl) and 
pCFJ104 (5 ng/µl). Selection was based on heat shock survival, wild type movement, no 
expression of mCherry markers and GFP expression.  Insertion of the transgene was confirmed by 
sequencing.  
 
Worm imaging. 
MitoTracker staining was performed as follows, approximately 2-3 day old adult worms were 
washed off NGM agar plates using M9 buffer. Worms were washed twice in M9 buffer, then once 
in MR buffer (10 µM MitoTracker Red CMXRos (Invitrogen) in M9 buffer), before being 
incubated in MR buffer for 2 hours on a rotating mixer at room temperature in the dark. The 
worms were then pelleted before being washed once with M9 buffer and being allowed to recover 
on a standard NGM agar plate for 1 hour at 20oC. They were then mounted on agarose pads and 
imaged at 100x magnification on a Leica DM5000B fluorescence microscope and images captured 
by Leica DFC340FX camera. Cells in the tail region were imaged. For NAC experiments, 
synchronised clk-1::gfp; his-24::mcherry worms were grown on untreated NGM agar plates or 
plates containing 10 mM NAC. Adult worms were imaged as described and the proportion of 
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nuclear CLK-1-GFP was determined by colocalisation with the HIS-24-mCherry nuclear marker. 
For hsp-6::gfp reporter assays between 40 and 60 young adult worms were mounted on agarose 
pads as described and imaged at 5x magnification. Fluorescence intensity was quantified using 
ImageJ. Images shown in Figures 1c and 3a are representative of 3 independent experiments.  
 
Measurement of worm ROS levels. 
ROS were measured using dihydroethidium (DHE). Briefly, synchronised adult worms were 
washed 3 times in PBS and then incubated in 3 µM DHE for 30 minutes. Following incubation 
worms were washed in PBS and then mounted on agarose pads and imaged at 63x magnification. 
The fluorescence intensity in the head of the worm was quantified using ImageJ. 
 
Paraquat sensitivity assay. 
Synchronised adult worms were treated with 40 mM Paraquat, dissolved in M9 buffer, for 6 hours 
in a 96 well plate. Approximately 20 worms were plated in each well, with each strain measured in 
triplicate. Survival was measured every 2 hours with worms being scored as dead if they failed to 
respond to gentle tapping of the plate. 
 
Lifespan assays. 
Lifespan assays were performed as described45. Briefly, 100 synchronized L1 stage worms were 
plated onto standard NGM agar plates spotted with OP50 bacteria. Upon reaching adulthood 
worms were transferred daily to fresh plates until egg laying ceased. Worms were scored daily, 
being judged as dead when they failed to respond to gentle prodding from a worm pick. Any 
worms that crawled off the plates during the assay were censored. Presented lifespan plots are 
representative of lifespan from the L1 larval stage from 3 independent experiments. The 
experiments were not randomised and the investigators were not blinded to allocation during 
experiments and outcome assessment. No statistical methods were used to predetermine sample 
size.  
 
Development assays 
Gravid adult worms were bleached and the embryos plated on NGM agar plates without food 
overnight. Synchronised L1 worms were transferred to spotted NGM plates and larval stage was 
determined every 24 hours until all of the worms reached adulthood. Approximately 50 worms per 
time point for each genotype were mounted on agarose pads and scored then discarded.   
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Worm RNA extraction. 
Synchronized L4 stage worms were pelleted and vortexed in 250 µl Trizol (Life Technologies) 
for 2 minutes and left for 30 minutes to dissolve. 50 µl chloroform was added and tubes vortexed 
for 2 minutes before centrifugation at 20, 000 g for 5 minutes. The supernatant was removed to a 
new tube and 125 µl propanol was added for 30 minutes before centrifugation at 20, 000 g for 5 
minutes. Supernatant was discarded and the pellet dissolved in RNase-free water. Contaminating 
DNA was removed using the DNA-free Kit (Life Technologies). 
 
Statistical analysis. 
Values are expressed as mean; error bars represent the standard error of the mean. Data were 
analysed, unless otherwise stated, using unpaired Student’s t-test and confidence given by the p 
values indicated in figure legends. For analysis of the proportion of cells with nuclear staining 
(Supplementary Fig. 1a) a z-test was used. For lifespan assays, survival time was estimated with 
the Kaplan–Meier method and the log-rank method was applied to compare survival curves. 
 
References 
 
 
∀! ,−.//0!12!3!45..560!72!789568:!;969/5<5=.!>5?<−>>≅65<=Α5−62! ∀#∃%&!!∀#0!
%%#Β%%∃0!Χ−5:∀+2∀+∃)∆%∗(%%#=!Ε#+∀∃Φ2!
#! 196=0!Γ2!72!3!ΗΙ=6Χ9.0!ϑ2!12!ΚΙΛ?5−.−85<=.!Μ−.9?!−/!>5Α−<Ι−6ΧΜ5=.!Μ9=<Α5Ν9!
−ΟΛ896!?Π9<59?2!∋()&∗∃)∀%+∗&))!!∃0!∀&)Β∀∋(0!
Χ−5:∀+2∀+∀∋∆Θ2>−.<9.2#+∀#2+∗2+#&!Ε#+∀#Φ2!
∃! Ρ≅60!Σ2!3!Τ56Υ9.0!ς2!Ω5Α−Ι−Μ>9?5?2!,&))+−&#∀.()/0−!%∀0!(&(Β(∋∋0!
Χ−5:∀+2∀+∀∋∆Θ2<>9Α2#+∀%2+∀2+∀∀!Ε#+∀%Φ2!
%! ,Ι9.=60!12!Κ2!3!Ξ≅<Υ9Μ;Μ=≅60!Ψ2!12!Ω5Α−<Ι−6ΧΜ5=.!?586=.568:!/−ΜΖ=ΜΧ?0!
;=<ΥΖ=ΜΧ?0!=6Χ!56!;9ΑΖ9962!12/3∀#/4&+−&3/∗/5&+∀53+∗&))∃)∀%+)(56&4/#7!
&∋%(0!∃&∀∋∀∃0!Χ−5:∀+2∀∀&&∆#+∀∃∆∃&∀∋∀∃!Ε#+∀∃Φ2!
&! ϑ=Μ8≅6Χ0!72!Ω20!Κ9..98Μ56−0!Ω2!,20!Τ5−Μ9?90!Η2!Σ20!Ψ=Υ9Μ0!Ψ2!Ω2!3![=Λ69?0!Η2!Ω2!
Ω5Α−<Ι−6ΧΜ5=.!5>Π−ΜΑ!9//5<596<Λ!−/!7ςΤ1Β∀!Μ98≅.=Α9?!>5Α−<Ι−6ΧΜ5=.!∴Κ]!
=<Α5Ν=Α5−62!8∗/&5∗&!((#0!&)(Β&∗+0!Χ−5:∀+2∀∀#∋∆?<596<92∀##∃&∋+!Ε#+∀#Φ2!
∋! [−≅ΑΥ−−Π9Μ0!]2![2+&#+∀)9!Ω5Α−6≅<.9=Μ!ΠΜ−Α956!5>;=.=6<9!=?!=!<−6?9ΜΝ9Χ!
.−689Ν5ΑΛ!>9<Ι=65?>2! ∀#∃%&!!∀#0!%&∀Β%&(0!Χ−5:∀+2∀+∃)∆6=Α≅Μ9∀#∀))!
Ε#+∀∃Φ2!
(! ,−680!720!Ψ−≅Α5?0!Κ2!3![9Υ5>50!12!Ω≅Α=Α5−6?!56!ΑΙ9!<.ΥΒ∀!8969!−/!
Η=96−ΜΙ=;Χ5Α5?!9.98=6?!=//9<Α!Χ9Ν9.−Π>96Α=.!=6Χ!;9Ι=Ν5−Μ=.!Α5>5682!
:&5&#/∗0!%(∀0!∀#%(Β∀#&∗!Ε∀∗∗&Φ2!
)! Σ−6=??960!ς2+&#+∀)9!Ρ9=?Α!Η.ΥΒ∀!Ι−>−.−8≅9!ΕΗ−⊥(∆Η=Α&Φ!5?!=!>5Α−<Ι−6ΧΜ5=.!
ΠΜ−Α956!56!<−96_Λ>9!!?Λ6ΑΙ9?5?2!;<&+=(∃%5∀)+(>+./()(6/∗∀)+∗<&−/0#%7!&#(0!
∃∃&∀Β∃∃&(!Ε∀∗∗)Φ2!
∗! ς=5Α0!12!,2!3!αΜ9960!42!]2!Ω5Α−<Ι−6ΧΜ5=!=6Χ!<9..!?586=..5682!=(∃%5∀)+(>+∗&))+
0∗/&5∗&!%&)0!)+(Β)∀&0!Χ−5:∀+2∀#%#∆Θ<?2+∗∗#∃%!Ε#+∀#Φ2!
! #∀!
∀+! ΗΙ=6Χ9.0!ϑ2!12!Ω5Α−<Ι−6ΧΜ5=!=?!?586=.568!−Μ8=69..9?2!?∋,+./()(67!%&0!∃%0!
Χ−5:∀+2∀∀)∋∆∀(%∀Β(++(Β∀#Β∃%!Ε#+∀%Φ2!
∀∀! α=..≅__50!Γ20!β9ΠΠ0!χ2!3!βΜ−9>9Μ0!α2!Ω5Α−<Ι−6ΧΜ5=:!>=?Α9Μ!Μ98≅.=Α−Μ?!−/!
Χ=689Μ!?586=..5682! ∀#∃%&+%&4/&≅09+∋()&∗∃)∀%+∗&))+./()(67!%(0!()+Β())0!
Χ−5:∀+2∀+∃)∆6Μ>∃%(∗!Ε#+∀#Φ2!
∀#! Ω=Μ;−5?0!Ψ2!ϑ2!3!Η.=ΜΥ90!Η2!Τ2!ςΙ9!Ηχ(!8969!96<−Χ9?!=!ΠΜ−Α956!56!
?=<<Ι=Μ−>Λ<9?!<9Μ9Ν5?5=9!69<9??=ΜΛ!/−Μ!≅;5⊥≅56−69!;5−?Λ6ΑΙ9?5?2!;<&+
=(∃%5∀)+(>+./()(6/∗∀)+∗<&−/0#%7!&#%0!#∗∗&Β∃++%!Ε∀∗∗∋Φ2!
∀∃! δΖ;=6Υ0!Σ2!Σ2+&#+∀)9!1ΑΜ≅<Α≅Μ=.!=6Χ!/≅6<Α5−6=.!<−6?9ΜΝ=Α5−6!−/!ΑΙ9!
Η=96−ΜΙ=;Χ5Α5?!9.98=6?!Α5>568!8969!<.ΥΒ∀2!8∗/&5∗&!&#)0!∗)+Β∗)∃!Ε∀∗∗(Φ2!
∀%! Σ−6=??960!ς20!Γ=Μ?960!Κ2!Γ2!3!Η.=ΜΥ90!Η2!Τ2!7!Χ59Α=ΜΛ!?−≅Μ<9!−/!<−96_Λ>9!!5?!
9??96Α5=.!/−Μ!8Μ−ΖΑΙ!−/!.−68Β.5Ν9Χ!Η=96−ΜΙ=;Χ5Α5?!9.98=6?!<.ΥΒ∀!>≅Α=6Α?2!
Α%(∗&&3/560+(>+#<&+!∀#/(5∀)+Β∗∀3&−7+(>+8∗/&5∗&0+(>+#<&+Χ5/#&3+8#∀#&0+(>+
Β−&%/∗∀!∀∃0!%#∀Β%#∋0!Χ−5:∀+2∀+(∃∆Π6=?2+#∀∃∃(%∗)!Ε#++∀Φ2!
∀&! Γ9Ν=Ν=??9≅Μ0!Τ2+&#+∀)9!∴;5⊥≅56−69!5?!69<9??=ΜΛ!/−Μ!>−≅?9!9>;ΜΛ−65<!
Χ9Ν9.−Π>96Α!;≅Α!5?!6−Α!9??96Α5=.!/−Μ!>5Α−<Ι−6ΧΜ5=.!Μ9?Π5Μ=Α5−62!;<&+
=(∃%5∀)+(>+./()(6/∗∀)+∗<&−/0#%7!&#∗0!%∋∀∋+Β%∋∀∋%0!
Χ−5:∀+2∀+(%∆Θ;<2Ω∀+)∗)+#++!Ε#++∀Φ2!
∀∋! Γ5≅0!ε2+&#+∀)9!δΝ−.≅Α5−6=ΜΛ!<−6?9ΜΝ=Α5−6!−/!ΑΙ9!<.ΥΒ∀ΒΧ9Π96Χ96Α!>9<Ι=65?>!
−/!.−689Ν5ΑΛ:!.−??!−/!><.Υ∀!56<Μ9=?9?!<9..≅.=Μ!/5Α69??!=6Χ!.5/9?Π=6!56!>5<92!
:&5&0+∆+3&4&)(Ε−&5#!%∀0!#%#%Β#%∃%0!Χ−5:∀+2∀∀+∀∆8=Χ2∀∃&#∗+&!Ε#++&Φ2!
∀(! Η.=Μ−?0!Ω2!α2!3!φ56<96?0!Κ2!Η−>Π≅Α=Α5−6=.!>9ΑΙ−Χ!Α−!ΠΜ9Χ5<Α!
>5Α−<Ι−6ΧΜ5=..Λ!5>Π−ΜΑ9Χ!ΠΜ−Α956?!=6Χ!ΑΙ95Μ!Α=Μ89Α568!?9⊥≅96<9?2!
Φ∃%(Ε&∀5+Γ(∃%5∀)+(>+./(∗<&−/0#%7+Η+ΙΦ?8!&!%0!((∗Β()∋!Ε∀∗∗∋Φ2!
∀)! Σ5=680!ϑ20!Γ9Ν=Ν=??9≅Μ0!Τ20!Ω<ΗΜ58ΙΑ0!Ψ20!1Ι−≅;Μ5Χ890!δ2!72!3![9Υ5>50!12!
Ω−≅?9!ΗΓβΒ∀!5?!5>Π−ΜΑ9Χ!56Α−!>5Α−<Ι−6ΧΜ5=!;Λ!=6!≅6≅?≅=.!ΠΜ−<9??!ΑΙ=Α!
Μ9⊥≅5Μ9?!=!.9=Χ9Μ!?9⊥≅96<9!;≅Α!6−!>9>;Μ=69!Π−Α96Α5=.2!;<&+=(∃%5∀)+(>+
./()(6/∗∀)+∗<&−/0#%7!&#∗0!#∗#∀)Β#∗##&0!Χ−5:∀+2∀+(%∆Θ;<2Ω∀+∃∋)∋#++!
Ε#++∀Φ2!
∀∗! ,Μ58ΙΑ0!α20!ς9Μ=Χ=0!β20!Ρ=6−0!Ω20!19Μ899Ν0!γ2!3!Ω−Μ50!Ω2!χΟ5Χ=Α5Ν9!?ΑΜ9??!
56Ι5;5Α?!ΑΙ9!>5Α−<Ι−6ΧΜ5=.!5>Π−ΜΑ!−/!ΠΜ9ΠΜ−Α956?!=6Χ!.9=Χ?!Α−!ΑΙ95Μ!
Χ98Μ=Χ=Α5−62!Φ2Ε&%/−&5#∀)+∗&))+%&0&∀%∗<!&∗(0!∀+(Β∀∀(0!
Χ−5:∀+2∀++∋∆9Ο<Μ2#+++2&+∗∋!Ε#++∀Φ2!
#+! Ρ=680!,2!3![9Υ5>50!12!7!>5Α−<Ι−6ΧΜ5=.!?≅Π9Μ−Ο5Χ9!?586=.!ΑΜ5889Μ?!
56<Μ9=?9Χ!.−689Ν5ΑΛ!56!Η=96−ΜΙ=;Χ5Α5?!9.98=6?2!Αϑ(8+./()(67!∃0!9∀+++&&∋0!
Χ−5:∀+2∀∃(∀∆Θ−≅Μ6=.2Π;5−2∀+++&&∋!Ε#+∀+Φ2!
#∀! 1≅_≅Υ50!12+&#+∀)9!ΚΙ−?ΠΙ=Α9Β=<Α5Ν=Α9Χ!8.≅Α=>56=?9!ΕαΓ1#Φ0!=!Π&∃Β56Χ≅<5;.9!
Μ98≅.=Α−Μ!−/!8.≅Α=>569!>9Α=;−.5?>!=6Χ!Μ9=<Α5Ν9!−ΟΛ896!?Π9<59?2!
Α%(∗&&3/560+(>+#<&+!∀#/(5∀)+Β∗∀3&−7+(>+8∗/&5∗&0+(>+#<&+Χ5/#&3+8#∀#&0+(>+
Β−&%/∗∀!%∋#0!(%∋∀Β(%∋∋0!Χ−5:∀+2∀+(∃∆Π6=?2∀++#%&∗∀+(!Ε#+∀+Φ2!
##! χηβ99/90!Γ2!φ2+&#+∀)9!4Μ−?−ΠΙ5.=!−ΜΑΙ−.−8≅9!−/!,,χε0!ΑΙ9!<ΙΜ−>−?−>=.!
/Μ=85.9!?5Α9!Τ]7∀∋4!Α≅>−≅Μ!?≅ΠΠΜ9??−Μ!89690!/≅6<Α5−6?!56!=9Μ−;5<!
>9Α=;−.5?>!=6Χ!Μ98≅.=Α9?!Μ9=<Α5Ν9!−ΟΛ896!?Π9<59?2!Κ∃−∀5+−()&∗∃)∀%+
6&5&#/∗0!&∋0!%∗(Β&+∗0!Χ−5:∀+2∀+∗∃∆Ι>8∆ΧΧ⊥%∗&!Ε#+∀∀Φ2!
#∃! ΗΜ5?Α56=0!420!Η=ΜΛ0!Ω20!Γ≅6<9/−ΜΧ0!720!Η.=ΜΥ90!Η2!3!β96Λ−60!Η2!7!Μ98≅.=Α9Χ!
Μ9?Π−6?9!Α−!5>Π=5Μ9Χ!Μ9?Π5Μ=Α5−6!?.−Ζ?!;9Ι=Ν5−Μ=.!Μ=Α9?!=6Χ!56<Μ9=?9?!
.5/9?Π=6!56!Η=96−ΜΙ=;Χ5Α5?!9.98=6?2!Αϑ(8+6&5&#/∗0!)0!9∀+++%&+0!
Χ−5:∀+2∀∃(∀∆Θ−≅Μ6=.2Π8962∀+++%&+!Ε#++∗Φ2!
! ##!
#%! φ=6!]==>?Χ−6Υ0!Σ2!Ω2+&#+∀)9!49<Μ9=?9Χ!969Μ8Λ!>9Α=;−.5?>!9ΟΑ96Χ?!.5/9!
?Π=6!56!Η=96−ΜΙ=;Χ5Α5?!9.98=6?!Ζ5ΑΙ−≅Α!Μ9Χ≅<568!−Ο5Χ=Α5Ν9!Χ=>=892!
:&5&#/∗0!%∃)0!&&∗Β&(∀0!Χ−5:∀+2∀&∃%∆8969Α5<?2∀∀+2∀∀&∃()!Ε#+∀+Φ2!
#&! 49ϑ5<−.=0!α2!Ω2+&#+∀)9!χ6<−8969Β56Χ≅<9Χ!ϑΜ/#!ΑΜ=6?<Μ5ΠΑ5−6!ΠΜ−>−Α9?!]χ1!
Χ9Α−Ο5/5<=Α5−6!=6Χ!Α≅>−Μ58969?5?2! ∀#∃%&!!#)0!∀+∋Β∀+∗0!
Χ−5:∀+2∀+∃)∆6=Α≅Μ9∀+∀)∗!Ε#+∀∀Φ2!
#∋! Κ=Π=0!Γ2!3!α9Μ>=560!42!δ?ΑΜ−896!Μ9<9ΠΑ−Μ!>9Χ5=Α9?!=!Χ5?Α56<Α!
>5Α−<Ι−6ΧΜ5=.!≅6/−.Χ9Χ!ΠΜ−Α956!Μ9?Π−6?92!=(∃%5∀)+(>+∗&))+0∗/&5∗&!%&!0!
∀∃∗∋Β∀%+#0!Χ−5:∀+2∀#%#∆Θ<?2+()##+!Ε#+∀∀Φ2!
#(! Κ9..98Μ56−0!Ω2!,20!ϑ=Μ8≅6Χ0!72!Ω2!3![=Λ69?0!Η2!Ω2!1586=.568!ΑΙ9!
>5Α−<Ι−6ΧΜ5=.!≅6/−.Χ9Χ!ΠΜ−Α956!Μ9?Π−6?92!?/(∗</−/∗∀+&#+./(Ε<70/∗∀+∀∗#∀!
%∃((0!%∀+Β%∀∋0!Χ−5:∀+2∀+∀∋∆Θ2;;=><Μ2#+∀#2+#2+∀∗!Ε#+∀∃Φ2!
#)! 7.ΧΜ5Χ890!Σ2!δ20![−Μ5;90!ς2!3![−−896Μ==Χ0!ϑ2!Σ2!45?<−Ν9ΜΛ!−/!8969?!=<Α5Ν=Α9Χ!
;Λ!ΑΙ9!>5Α−<Ι−6ΧΜ5=.!≅6/−.Χ9Χ!ΠΜ−Α956!Μ9?Π−6?9!Ε>Α∴Κ]Φ!=6Χ!<−86=Α9!
ΠΜ−>−Α9Μ!9.9>96Α?2!Α)(8+(5&!&0!9)(%0!Χ−5:∀+2∀∃(∀∆Θ−≅Μ6=.2Π−692++++)(%!
Ε#++(Φ2!
#∗! β=Λ?9Μ0!δ2!Ψ20!19Χ96?ΥΛ0!Ω2!Ω20!Ω−Μ8=60!Κ2!α2!3![−ΠΠ9.0!Η2!Γ2!Ω5Α−<Ι−6ΧΜ5=.!
−Ο5Χ=Α5Ν9!ΠΙ−?ΠΙ−ΜΛ.=Α5−6!5?!Χ9/9<Α5Ν9!56!ΑΙ9!.−68Β.5Ν9Χ!>≅Α=6Α!<.ΥΒ∀2!;<&+
=(∃%5∀)+(>+./()(6/∗∀)+∗<&−/0#%7!&#∀0!&%%(∗Β&%%)∋0!
Χ−5:∀+2∀+(%∆Θ;<2Ω%+∃+∋∋#++!Ε#++%Φ2!
∃+! Ψ≅Α.9Μ0!Σ2!720!Ω5?Ι≅Μ0!]2!Σ20!ΨΙ=?Υ=Μ=60!12!3!]9=0!12!Γ2!7!>9Α=;−.5<!?586=Α≅Μ9!
/−Μ!.−68!.5/9!56!ΑΙ9!Η=96−ΜΙ=;Χ5Α5?!9.98=6?!Ω5Α!>≅Α=6Α?2!Β6/56+∗&))!%&0!∀∃+Β
∀∃)0!Χ−5:∀+2∀∀∀∀∆=<9.2∀#+#∗!Ε#+∀∃Φ2!
∃∀! 1<Ι≅._0!ς2!Σ2+&#+∀)9!α.≅<−?9!Μ9?ΑΜ5<Α5−6!9ΟΑ96Χ?!Η=96−ΜΙ=;Χ5Α5?!9.98=6?!.5/9!
?Π=6!;Λ!56Χ≅<568!>5Α−<Ι−6ΧΜ5=.!Μ9?Π5Μ=Α5−6!=6Χ!56<Μ9=?568!−Ο5Χ=Α5Ν9!
?ΑΜ9??2!,&))+−&#∀.()/0−!∗0!#)+Β#∗∃0!Χ−5:∀+2∀+∀∋∆Θ2<>9Α2#++(2+)2+∀∀!
Ε#++(Φ2!
∃#! Γ990!12!Σ20![Ζ=680!72!Ψ2!3!β96Λ−60!Η2!γ6Ι5;5Α5−6!−/!Μ9?Π5Μ=Α5−6!9ΟΑ96Χ?!Η2!
9.98=6?!.5/9!?Π=6!Ν5=!Μ9=<Α5Ν9!−ΟΛ896!?Π9<59?!ΑΙ=Α!56<Μ9=?9![γΤΒ∀!=<Α5Ν5ΑΛ2!
,∃%%&5#+./()(67+Λ+,?!&∋0!#∀∃∀Β#∀∃∋0!Χ−5:∀+2∀+∀∋∆Θ2<≅;2#+∀+2∀+2+&(!
Ε#+∀+Φ2!
∃∃! χΖ≅?≅Β76?=Ι0!δ20!1−680!,2!3!Κ9ΜΜ5>−60!ϑ2!Ω≅?<.9!>5Α−Ι−Μ>9?5?!ΠΜ−>−Α9?!
.−689Ν5ΑΛ!Ν5=!?Λ?Α9>5<!Μ9ΠΜ9??5−6!−/!56?≅.56!?586=.5682!,&))!%))0!∋∗∗Β(∀#0!
Χ−5:∀+2∀+∀∋∆Θ2<9..2#+∀∃2+∗2+#∀!Ε#+∀∃Φ2!
∃%! Ψ=ΜΒΚ9.9Χ0!Ω2!3!]=5ΥΙ9.0!ϑ2!φ2!7!>9ΑΙ−Χ!/−Μ!5?−.=Α5−6!=6Χ!Π≅Μ5/5<=Α5−6!−/!
?Π9<5/5<!=6Α5;−Χ59?!Α−!=!ΠΜ−Α956!/≅?9Χ!Α−!ΑΙ9!α1ς2!Β5∀)7#/∗∀)+./(∗<&−/0#%7!
&!%0!∀%+Β∀%#0!Χ−5:∀+2∀++∋∆=;5−2∀∗∗∋2+∃∗+!Ε∀∗∗∋Φ2!
∃&! ,Ι5Α>=Μ?Ι0!72!Σ2!3!4=Ν5?0!]2!Σ2!76=.Λ_568!Σϑβ!=6Χ!Π∃)!>5Α−896Β=<Α5Ν=Α9Χ!
ΠΜ−Α956!Υ56=?9!=<Α5Ν5ΑΛ2!∋&#<(30+/5+&5Μ7−()(67!((&0!∃∀∗Β∃∃∋!Ε#++∀Φ2!
∃∋! ΤΜ9__=0!Η20!Η5Π−.=Α0!12!3!1<−ΜΜ=6−0!Γ2!χΜ8=69..9!5?−.=Α5−6:!/≅6<Α5−6=.!
>5Α−<Ι−6ΧΜ5=!/Μ−>!>−≅?9!.5Ν9Μ0!>≅?<.9!=6Χ!<≅.Α≅Μ9Χ!/5;Μ−;.=?Α?2! ∀#∃%&+
Ε%(#(∗()0!&0!#)(Β#∗&0!Χ−5:∀+2∀+∃)∆6ΠΜ−Α2#++∋2%()!Ε#++(Φ2!
∃(! Γ5Ν=Υ0!β2!Σ2!3!1<Ι>5ΑΑ8960!ς2!42!76=.Λ?5?!−/!Μ9.=Α5Ν9!8969!9ΟΠΜ9??5−6!Χ=Α=!
≅?568!Μ9=.ΒΑ5>9!⊥≅=6Α5Α=Α5Ν9!ΚΗ]!=6Χ!ΑΙ9!#ΕΒ49.Α=!49.Α=!ΗΕςΦΦ!Ω9ΑΙ−Χ2!
∋&#<(30!&)0!%+#Β%+)0!Χ−5:∀+2∀++∋∆>9ΑΙ2#++∀2∀#∋#!Ε#++∀Φ2!
∃)! Ω5Λ=Χ9Μ=0![2+&#+∀)9!≅56−69?!56!.−68Β.5Ν9Χ!<.ΥΒ∀!>≅Α=6Α?!−/!Η=96−ΜΙ=;Χ5Α5?!
9.98=6?2!ΙΦ?8+)&##&%0!)%&0!∃∃Β∃(!Ε#++#Φ2!
∃∗! ,=680!Ρ2+&#+∀)9!ςΙ9!=6Α5Β69≅Μ−Χ98969Μ=Α5−6!ΧΜ≅8!<.5−⊥≅56−.!56Ι5;5Α?!ΑΙ9!
=8568Β=??−<5=Α9Χ!ΠΜ−Α956!ΗΓβΒ∀2!;<&+=(∃%5∀)+(>+./()(6/∗∀)+∗<&−/0#%7!&∃!0!
∃∀%Β∃#∃0!Χ−5:∀+2∀+(%∆Θ;<2Ω)+(&(∗#++!Ε#++∗Φ2!
! #∃!
%+! Ω5Μ_−9Ν=0!χ2!β2!3!Κ9ΑΜ5650!Σ2![2!4ϑ7!Μ9Π.5<=Α5−6ΒΧ9Π96Χ96Α!6≅<.9=Μ!
ΧΛ6=>5<?!−/!ΑΙ9!ΩΜ9∀∀!<−>Π.9Ο2!∋()&∗∃)∀%+∗∀5∗&%+%&0&∀%∗<+Λ+∋,Ν!%0!#+(Β
#∀)!Ε#++∃Φ2!
%∀! 7Π=Μ5<5−0!χ2+&#+∀)9!ΗΙΜ−>=Α56!5>>≅6−ΠΜ9<5Π5Α=Α5−6!/−Μ!Χ9Α9Μ>56568!ΑΙ9!
=??−<5=Α5−6!−/!ΠΜ−Α956?!Ζ5ΑΙ!?Π9<5/5<!896−>5<!?9⊥≅96<9?!56!Ν5Ν−2!,∃%%&5#+
Ε%(#(∗()0+/5+−()&∗∃)∀%+./()(67+Η+&3/#&3+.7+Ι%&3&%/∗Ο+∋9+Β∃0∃.&)+999+Π&#+∀)9Θ!
+,−./012&%0!∴65Α!#∀!#∃0!Χ−5:∀+2∀++#∆+%(∀∀%#(#(2>;#∀+∃?∋∗!Ε#++&Φ2!
%#! ΨΜ9669Μ0!12!ςΙ9!8969Α5<?!−/!Η=96−ΜΙ=;Χ5Α5?!9.98=6?2!:&5&#/∗0!##0!(∀Β∗%!
Ε∀∗(%Φ2!
%∃! ΤΜ−ΥΘ=9ΜΒΣ96?960!Η2+&#+∀)9!1568.9Β<−ΠΛ!56?9ΜΑ5−6!−/!ΑΜ=6?8969?!56!
Η=96−ΜΙ=;Χ5Α5?!9.98=6?2! ∀#∃%&+6&5&#/∗0!!∋0!∀∃(&Β∀∃)∃0!
Χ−5:∀+2∀+∃)∆682#%)!Ε#++)Φ2!
%%! Ξ95?9Μ0!δ20!ΤΜ−ΥΘ=9ΜΒΣ96?960!Η20!Σ−Μ896?960!δ2!3!7ΙΜ5689Μ0!Σ2!Ω−?1Ηγ!=6Χ!
8=Α9Ζ=Λ!<−>Π=Α5;.9!Π.=?>5Χ!Α−−.Υ5Α!/−Μ!<−6?Α5Α≅Α5Ν9!=6Χ!56Χ≅<5;.9!
9ΟΠΜ9??5−6!−/!ΑΜ=6?8969?!56!ΑΙ9!Η2!9.98=6?!89Μ>.5692!Α)(8+(5&!∗0!9#++)#0!
Χ−5:∀+2∀∃(∀∆Θ−≅Μ6=.2Π−692++#++)#!Ε#+∀∀Φ2!
%&! Γ=Υ−Ζ?Υ50!Ψ2!3![9Υ5>50!12!49Α9Μ>56=Α5−6!−/!.5/9Β?Π=6!56!Η=96−ΜΙ=;Χ5Α5?!
9.98=6?!;Λ!/−≅Μ!<.−<Υ!8969?2!8∗/&5∗&!&#&0!∀+∀+Β∀+∀∃!Ε∀∗∗∋Φ2!
 
 
Acknowledgments  
We thank M. Howard for assistance with RP-HPLC. This work was supported by the 
Biotechnology and Biological Sciences Research Council [BB/J014834/1] and the Wellcome 
Trust [093176/Z/10/Z and 097820/Z/11/Z]. We thank A. Sharrocks, P. Shore, S.H. Yang and A. 
Gilmore for helpful comments on the manuscript. The authors declare that they have no 
competing financial interests.  
 
Contributions 
R.M.M. conceived and designed the study, performed the majority of the experiments, analysed 
the data and wrote the paper; R.G.B. generated worm strains, imaged worms and conducted 
lifespan experiments; K.F. generated worm strains; T.A. and N.R. screened non-nuclear COQ7 
mutants; G.B.P. conceived and designed the study; A.J.W. conceived and designed the study, 
analysed the data and wrote the paper.  
 
Competing financial interests 
! #%!
The authors declare no competing financial interests. 
 
Figure Legends 
 
Figure 1: CLK-1 and its human homologue COQ7 localise to both mitochondria and nuclei.  
(a) Endogenous COQ7 and COXIV (mitochondrial marker) immunostaining in HeLa cells. 
Nuclei stained with DAPI. (b) HeLa cells expressing COQ7 tagged at the C-terminus with Myc 
epitope (COQ7-myc) were stained with anti-Myc and anti-COXIV antibodies. Quantification of 
nuclear COQ-7-Myc staining is in Supplementary Fig. 1a. (c) Wild type CLK-1 (CLK-1wt) fused 
at the C-terminus to GFP localises to both mitochondria and nuclei in adult C. elegans. Arrow 
marks nuclei. MT (MitoTracker, mitochondrial marker). (d) HeLa cells immunostained with an 
antibody specific to the N-terminus (amino acids 1-36) of COQ7 (COQ7N-term). (e) Nuclear 
staining of endogenous COQ7 is decreased by antioxidant N-acetyl-L-cysteine (NAC, 10 mM, 24 
h). 50 HeLa cells assessed in 3 independent experiments (error bars, s.e.m. *P < 0.05). (f) Percent 
of mCherry-positive nuclei that are also GFP-positive in C. elegans expressing CLK-1-GFP and 
the nuclear marker HIS-24-mCherry. 25 worms assessed in 3 independent experiments (error 
bars, s.e.m. **P < 0.005). (g) The ratio of nuclear (uncleaved) to mitochondrial (mito, cleaved) 
COQ7 in lysates from HEK293 was quantified from 3 independent immunoblotting experiments 
(error bars, s.e.m. *P < 0.05, **P < 0.005). Cells were treated with hydrogen peroxide (H2O2, 150 
µM, 3h; cellular ROS) or rotenone (50 µM, 3 h; complex I inhibitor, mitochondrial ROS), with or 
without 10 mM NAC. A representative immunoblot is shown. (h) Blocking mitochondrial 
targeting of COQ7 enhances nuclear localisation of uncleaved COQ7. HeLa cells expressing the 
COQ7 (R11/14/16D) mutant, that disrupts mitochondrial targeting, fused at the C-terminus to the 
Myc epitope were immunostained with anti-Myc and anti-COXIV antibodies.  
 
Figure 2: Nuclear COQ7 supports cell proliferation without affecting ubiquinone levels.  
(a) Reduced nuclear localisation of the COQ7 (R28A) mutant. Fluorescence in COS7 cells 
expressing COQ7 or COQ7 (R28A) fused at the C-terminus to GFP. Nuclei stained with DAPI. 
(b) Schematic depicting location of the mitochondrial targeting sequence (MTS), the nuclear 
targeting sequence (NTS) and the mitochondrial processing peptidase cleavage site (MPP) on 
COQ7. The N-terminal region of COQ7 is degraded following cleavage by MPP in mitochondria. 
Also shown are positions of the OLLAS and FLAG epitope-tags. (c) HeLa cells expressing dual 
OLLAS and FLAG tagged COQ7 or COQ7 (R28A) immunostained with anti-FLAG and anti-
OLLAS antibodies. The anti-FLAG antibodies recognise total COQ7 (uncleaved and cleaved) and 
! #&!
the anti-OLLAS antibody specifically recognises uncleaved nuclear COQ7. (d) Immunoblot of 
cell lysates from HEK293 cells stably expressing either wild type (WT) COQ7 or the R28A 
mutant in the presence of siRNA against untranslated regions of COQ7. R28A cells display a 
decrease in nuclear uncleaved COQ7. Quantification of the ratio of uncleaved (nuclear) to cleaved 
(Mito, mitochondrial) COQ7 from 3 independent experiments is presented (error bars, s.e.m. **P 
< 0.005). (e) Immunoblot of cell lysates from the stable HEK293 cells expressing either wild type 
(WT) COQ7 or the R28A mutant separated into mitochondrial and nuclear pellet fractions. 
COXIV (mitochondrial marker), Lamin B1 (nuclear matrix marker). Uncropped images of blots 
are shown in Supplementary Fig. 7. (f) Ubiquinone (UQ10) levels are similar in COQ7 WT and 
R28A cells. Reverse-phase HPLC chromatograms of quinones purified from cells (UQ10 peak at 
8.63 minutes). (g) Proliferation of COQ7 (R28A) expressing cells was reduced compared to 
COQ7 WT cells as measured by MTT assay (mean values from 4 wells of cells per condition in 3 
independent experiments; error bars, s.e.m. *P < 0.05). Cell survival was not altered under these 
conditions (see Supplementary Fig. 4f). 
 
Figure 3: Nuclear CLK-1/COQ7 regulates cellular ROS metabolism.   
(a) CLK-1 lacking the MTS (CLK-1nuc(+)) is predominantly nuclear in adult worms. Arrows mark 
nuclei. MT (MitoTracker, mitochondrial marker). (b) Nuclear CLK-1 acts to lower cellular ROS 
levels. Expression the nuclear form of CLK-1 (clk-1nuc(+)) partially rescued the increased ROS 
phenotype of clk-1 null worms (clk-1(-)) as measured by the ROS-sensitive dye DHE. Wild-type 
CLK-1-GFP (clk-1wt) completely rescues the phenotype (25 worms assessed in 3 independent 
experiments; error bars, s.e.m. **P < 0.005, ***P < 0.001).  (c) Expression of CLK-1nuc(+) in clk-
1 null worms significantly increases their survival in response to treatment with paraquat (40mM; 
respiration inhibitor). CLK-1wt expression in clk-1 null worms rescues survival to levels similar to 
N2 worms (25 worms assessed in 3 independent experiments; error bars, s.e.m. **P < 0.01). (d) 
Increased levels of ROS in untreated and oxidative stress treated (100 µM tert-butyl 
hydroperoxide, 1 h) HEK293 cells expressing non-nuclear COQ7 (R28A) compared to wild type 
(WT), monitored by DCF fluorescence (mean values from 4 wells of cells per condition in 3 
independent experiments; error bars, s.e.m. *P < 0.05, **P < 0.005). (e) Nuclear COQ7 promotes 
resistance to ROS insults. Increased sensitivity of R28A cells to oxidative stress (1 mM CoCl2, 4 
h) measured by MTT assay (mean values from 4 wells of cells per condition in 3 independent 
experiments; error bars, s.e.m. *P < 0.05). (f, g) Nuclear CLK-1 regulates genes involved in ROS 
metabolism. The altered transcript levels of glna-1 and dhs-7 in clk-1 null worms are rescued by 
expression of CLK-1nuc(+) (mean values from 3 reactions per condition for 3 independent 
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experimental repeats; error bars, s.e.m. *P < 0.05). (h) The transcript levels of the glna-1 and dhs-
7 homologues, GLS2 and WWOX, are decreased or increased, respectively, upon loss of nuclear 
COQ7 (R28A compared to WT) (mean values from 3 reactions per condition for 4 independent 
experiments; error bars, s.e.m. *P < 0.05, **P < 0.005). (i) The transcript levels of HTRA2, 
encoding a proapoptotic mitochondrial protease, are increased in cells lacking nuclear COQ7 
(R28A compared to WT) (mean values from 3 reactions per condition for 4 independent 
experiments; error bars, s.e.m. **P < 0.005). (j) Immunoblots of corresponding protein levels for 
gene transcripts analysed in Fig. 3h, i and Supplementary Fig. 4f (NRF2). Quantification from 3 
repeats of the GLS2, WWOX and HTRA2 blots are shown in Supplementary Fig. 4g. Uncropped 
images of these blots are shown in Supplementary Fig. 7. (k) The ROS sensitivity phenotype 
observed upon loss of nuclear COQ7 is in part due to increased HTRA2 expression. Inhibition of 
HTRA2 activity (10 mM UCF-101, 30 min) rescues the ROS sensitivity of COQ7 (R28A) cells 
following oxidative stress (1 mM CoCl2, 4 h). Measured by MTT assay relative to DMSO treated 
cells (mean values from 4 wells of cells per condition in 3 independent experiments; error bars, 
s.e.m. *P < 0.05). 
 
Figure 4: Nuclear CLK-1 regulates lifespan and suppresses UPR
mt
 gene expression. 
(a, b) CLK-1nuc(+) expression partially rescues the increased lifespan observed in clk-1(-) worms 
while CLK-1wt completely rescues the longevity phenotype. Lifespan plotted as percent survival 
and mean lifespans calculated. N2 is the wild type strain. Lifespan data, including mean, 
maximum and 90th percentile lifespan with statistical analysis, for 3 independent experimental 
repeats is reported in Supplementary Table 1. (c) CLK-1nuc(+) expressing worms display decreased 
hsp-6::gfp reporter activity compared to clk-1(-) worms. Quantification of reporter fluorescence 
in CLK-1nuc(+) expressing worms (clk-1(-); clk-1nuc(+)) relative to clk-1(-) worms (mean 
fluorescence of 50 worms per genotype pooled from 3 independent experiments; error bars, s.e.m. 
**P < 0.005). (d) qPCR measuring mRNA transcripts of UPRmt genes in clk-1(-) or clk-1(-); clk-
1
nuc(+) worms relative to wild type strain (N2) (mean values from 3 reactions per condition in 3 
independent experiments; error bars, s.e.m. n.s., no significant difference, *P < 0.05). (e) Heat 
map depicting change in expression of UPRmt genes (MT) and UPRER (ER) genes in R28A cells 
compared to WT COQ7 cells. Map generated from the qPCR data presented in Supplementary 
Figure 5c and is representative of 3 independent experiments. Scale represents mean fold change 
in expression. (f) Immunoblots of protein levels including the mitochondrial controls COXIV 
(nuclear-encoded) and MTCO1 (mitochondrial-encoded). Uncropped images of blots are shown 
in Supplementary Fig. 7. 
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Figure 5: COQ7 associates with chromatin.   
(a) Chromatin fractionation of HEK293 cells expressing wild type or R28A (non-nuclear mutant) 
COQ7 tagged within the N-terminus with OLLAS, as shown in Fig. 2b, followed by anti-COQ7 
immunoprecipitation and anti-OLLAS immunoblot. Each fraction was also immunoblotted for the 
markers Tubulin β (cytosolic), c-Jun (active chromatin), Lamin B1 (nuclear matrix). TS, triton-
soluble fraction; DS, DNase-soluble fraction. (b) Schematic of the WWOX and TIMM22 COQ7-
associated promoter sites enriched in anti-COQ7 ChIPs compared to IgG control. Full data set 
and statistics of enriched sites are provided in Supplementary Table 2. (c) Anti-COQ7 ChIP was 
performed on HEK293 cells expressing wild type (WT) or the mitochondrial-only form (R28A) 
of COQ7 before qPCR analysis of WWOX and TIMM22 promoter sites and two control intergenic 
sites (mean values from 3 reactions per condition in 3 independent experiments; error bars, s.e.m. 
n.s., no significant difference, **P < 0.005). (d) Anti-COQ7 ChIP was performed on HEK293 
cells treated with antioxidant (N-acetyl cysteine, NAC, 10 mM, 24 h) compared to untreated 
(mean values from 3 reactions per condition in 3 independent experiments; error bars, s.e.m. n.s., 
no significant difference, *P < 0.05). (e) Model depicting the dual mitochondrial and nuclear role 
of CLK-1/COQ7 in regulating ROS homeostasis. Mitochondrial CLK-1/COQ7 regulates 
ubiquinone (UQ) biosynthesis and respiration via the electron transport chain (ETC), whilst 
nuclear CLK-1/COQ7, through modulation of gene expression, regulates ROS metabolism and 
suppresses the UPRmt.  
 
 
 
Supplementary information 
 
Supplementary Figure 1: A distinct pool of COQ7 localises to the nucleus. 
(a) HeLa cells expressing COQ7-Myc were scored for mitochondrial, nuclear, mitochondrial and 
nuclear, or disperse COQ7 immunostaining (100 cells assessed in each of 3 independent 
experiments; error bars, s.e.m. **P < 0.005 compared to other localisations). Representative 
image of cells is shown in Fig. 1b. (b) The region of COQ7 required for nuclear localisation 
resides between amino acids 11 and 29. GFP fluorescence of COS7 cells expressing GFP-COQ7 
and the deletion mutants GFP-COQ7(11-217), lacking amino acids 1-10, and GFP-COQ7(30-
217), lacking amino acids 1-29. Orientating the GFP tag on the N-terminus of COQ7 abolished 
mitochondrial localisation and promoted nuclear localisation, probably due to disruption of the 
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interaction between the N-terminal MTS and the mitochondrial import machinery. Mitochondria 
are stained with MitoTracker (MT) and nuclei with DAPI. Schematic depicts the GFP-COQ7 
deletion mutants used and summarises their localisation. (c) Endogenous uncleaved COQ7 is 
nuclear. HeLa cells immunostained with a second antibody specific to the N-terminus of COQ7 
(COQ7N-term2). (d) siRNA targeting COQ7 transcripts decrease levels of both cleaved and 
uncleaved COQ7 protein. Immunoblots of lysates from HEK293 cells transfected with non-
targeting (CTRL) or COQ7 siRNA. Short and long exposures of the immunoblots are shown. (e) 
Immunoblot demonstrating that uncleaved wild type COQ7 (WT) migrates at the same position as 
COQ7 S36A (containing a point mutation in the predicted mitochondrial processing peptidase 
cleavage site) and that cleaved COQ7 migrates at the same position as COQ7(37-217) that lacks 
the N-terminal region cleaved by MPP. * denotes an aberrantly cleaved form of COQ7 S36A. (f) 
Uncleaved COQ7 is found in the nuclear fraction of cells. HEK293 cells treated with or without 
hydrogen peroxide (150 µM H2O2, 3 h) were fractionated into mitochondrial (mito) and a pellet 
fraction (containing nuclei and insoluble material). Fractions were immunoblotted for COQ7 and 
appropriate localisation markers; VDAC and COXIV for the mitochondrial fraction; c-Jun and 
Lamin B1 for the nuclear fraction. The presence of mitochondrial proteins, plus the cleaved 
mitochondrial form of COQ7, in the nuclear fraction indicates that the nuclear pellets contain 
some mitochondrial contamination.  
 
Supplementary Figure 2: COQ7 nuclear localisation is dependent on ROS.   
(a) Nuclear staining intensity of cells immunostained with anti-COQ7(1-36) (COQ7N-term) 
following treatment with antioxidant (N-acetyl cysteine, NAC, 10 mM, 24 h) or low and high 
levels of exogenous ROS (hydrogen peroxide, 200 µM or 800 µM, respectively, 3 h) compared to 
untreated (0) control. 50 cells assessed in 3 independent experiments (error bars, s.e.m. 
*P < 0.05). (b) Immunoblots of lysates from HEK293 cells expressing COQ7-Myc or COQ7 
(R11/14/16D)-Myc (mutant that disrupts mitochondrial targeting) treated with H2O2 (150 µM, 4 
h) or NAC (10 mM, 6 h). NT = untreated cells. Uncropped images of blots are shown in 
Supplementary Fig. 7. (c) The intensity of nuclear anti-Myc immunostaining in HeLa cells 
expressing COQ7-Myc or COQ7-R11/14/16D-Myc was quantified (50 cells assessed in each of 3 
independent experiments; error bars, s.e.m. n.s., no significant difference, *P < 0.05 relative to 
untreated).  
 
Supplementary Figure 3: Identifying a non-nuclear mutant of COQ7.  
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(a) Alignment of mammalian COQ7 N-terminal protein sequences (amino acids 1 to 42) using 
Clone Manager; HS, Homo sapiens; CL, Canis lupus familiaris; MM, Mus musculus; RN, Rattus 
norvegicus. Conserved residues are in red and R28 is in blue. MPP marks the mitochondrial 
processing peptidase cleavage site. Residues mutated and used in the fluorescence studies in panel 
b are denoted with asterisks. (b) Mutations in the COQ7 N-terminus cause reduced nuclear 
localisation. GFP fluorescence in COS7 cells expressing COQ7 fused at the C-terminus to GFP 
and harboring the point mutations R21A, Y26F and R28A was analysed. Quantification of the 
percent of cells displaying nuclear staining is shown (40 cells assessed in each of 3 independent 
experiments; error bars, s.e.m. **P < 0.005). The most significant loss of nuclear staining was 
observed with the R28A mutation. (c) COQ7 (R28A) mutant displays reduced levels of the 
uncleaved form. Lysates from HEK293 cells expressing OLLAS and FLAG tagged COQ7 
(COQ7O/F) or COQ7(R28A)O/F were immunoblotted with anti-COQ7 antibody. (d) Parent 
HEK293 cells (Ctrl) or cells stably expressing untagged (WT) or non-nuclear COQ7 (R28A) were 
transfected with siCTRL or siCOQ7 that specifically targets endogenous COQ7 mRNA. 
Transcript levels of endogenous COQ7 mRNA (5’UTR amplicon) were analysed (mean values 
from 3 reactions per condition in 4 independent experiments; error bars, s.e.m. **P < 0.005). (e) 
Reverse-phase HPLC chromatograms of quinones. Purified ubiquinone-10 (UQ10) was used as a 
standard. Levels of UQ10 and demethoxyubiquinone-10 (DMQ10) were measured in HEK293 
cells treated with the COQ7 inhibitor clioquinol (CQ; 10 µM, 24 h), or from WT or R28A 
expressing HEK293 cells. CQ caused the appearance of DMQ10. UQ10 peak at 8.63 mins, 
DMQ10 peak at 8.39 mins. (f) Levels of lactate dehydrogenase (LDH) in media from cultured 
WT and R28A cells are similar, indicating that cell survival under basal conditions is not changed 
(mean values from 4 wells of cells per condition in 3 independent experiments; error bars, s.e.m. 
**P < 0.005). Treatment with 0.1% (v/v) Triton X-100 (TX) for 30 minutes was used as a 
positive control.  
 
Supplementary Figure 4: Nuclear COQ7/CLK-1 regulates ROS metabolic gene expression 
independently of ubiquinone biosynthesis.   
(a) The mechanism of targeting of C. elegans CLK-1 and human COQ7 to nuclei is not 
conserved. Alignment of the N-termini and the start of the highly conserved diiron binding 
domains of CLK-1 and COQ7. The mitochondrial targeting sequences (MTS) are denoted by the 
black bars, conserved amino acids are highlighted in blue, the predicted mitochondrial processing 
peptidase (MPP) sites for both proteins is shown, the region in COQ7 containing determinants of 
nuclear localisation is denoted by the red bar and the residues required for nuclear-targeting are 
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highlighted in red. CE, C. elegans; HS, Homo sapiens (b) CLK-1nuc(+) expression does not rescue 
the loss of mitochondrial ubiquinone (UQ9) biosynthesis in clk-1(-) worms. Reverse-phase HPLC 
chromatograms of quinones extracted from the indicated strains (UQ9 peak at 8.78 minutes, 
DMQ9 peak at 8.42 minutes). CLK-1wt but not CLK-1nuc(+) restores the UQ9 peak loss in clk-1 
(clk-1(-)) null worms. (c) Expression of the nuclear form of CLK-1 (clk-1nuc(+)) in clk-1 null 
worms (clk-1(-)) partially rescues the increased levels of ROS observed in these worms measured 
using the ROS-sensitive dye DHE. Quantification of staining is presented in Fig. 3b. (d) Nuclear 
CLK-1 regulates the expression of genes involved in ROS metabolism. qPCR analysis of 
transcripts from ROS-sensitive retrograde genes relative to N2 (mean values from 3 reactions per 
condition in 3 independent experiments; error bars, s.e.m. *P < 0.05 for clk-1(-) compared to 
other strains). (e) CLK-1nuc(+) rescues the increased transcript levels of genes known to be 
responsive to ROS (sod-2 and skn-1) in clk-1 null worms (mean values from 3 reactions per 
condition in 3 independent experiments; error bars, s.e.m. *P < 0.05 for clk-1(-) compared to 
other strains). (f) Homologues of these genes, SOD2 and NRF2, and the NRF2 target gene 
HMOX1 are increased in cells that have lost nuclear COQ7 (R28A) (mean values from 3 reactions 
per condition for 4 independent experiments; error bars, s.e.m. *P < 0.05). (g) Quantification of 
immunoblots for GLS2, WWOX and HTRA2 proteins (mean values from 3 independent 
experiments; error bars, s.e.m. *P < 0.05, **P < 0.005). Representative blots are shown in Fig. 3j. 
 
Supplementary Figure 5: Nuclear CLK-1 does not rescue the developmental phenotype of 
CLK-1 null worms but does regulate the expression of UPR
mt
 genes.  
(a) Analysis of developmental timing. Worms were synchronised at L1 and larval stage was 
determined every 24 hours until all of the worms reached adulthood. Approximately 50 worms per 
genotype were monitored for each time point (mean values from 3 independent experiments; error 
bars, s.e.m.).  (b) qPCR analysis of UPRmt genes in CLK-1 transgenic worm strains relative to N2 
(mean values from 3 reactions per condition in 3 independent experiments; error bars, s.e.m. n.s., 
no significant difference, *P < 0.05). The increase in expression of hsp-6, hsp-60 and spg-7 in clk-
1(-) worms was abrogated by expression of either CLK-1wt or CLK-1nuc(+). mRNA levels of the 
endoplasmic reticulum UPR (UPRER)-regulated gene hsp-4 were not changed in any of the worm 
strains. (c) qPCR of analysis of transcripts of UPRmt genes and UPRER genes in WT and R28A 
expressing HEK293 cells (mean values from 3 reactions per condition in 4 independent 
experiments; error bars, s.e.m. *P < 0.05. **P < 0.005). Heatmap of this data is shown in Fig. 4e. 
(d) The ratio of COXIV to MTCO1 protein levels in WT and R28A expressing cells quantified 
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from 3 independent immunoblots (error bars, s.e.m. n.s., no significant difference). See Fig. 4f for 
representative immunoblot.  
 
Supplementary Figure 6: Model for the regulation of ROS metabolism, the UPR
mt
 and 
lifespan by nuclear CLK-1/COQ7.  
(a) CLK-1/COQ7 regulates mitochondrial homeostasis. The majority of CLK-1/COQ7 localises 
to mitochondria by means of its mitochondrial targeting sequence (MTS), where it is required for 
ubiquinone (UQ) biosynthesis, an essential cofactor in the electron transport chain (ETC). 
However, basal levels of ROS, produced by the mitochondria, direct a pool of CLK-1/COQ7 to 
the nucleus where it regulates gene expression. Some CLK-1/COQ7-regulated genes are directly 
involved in mitochondrial ROS metabolism and therefore, the prolonged presence of CLK-
1/COQ7 in the nucleus instigates a decrease in ROS production to suboptimal levels. Reduced 
ROS leads to CLK-1/COQ7 being predominantly localised to mitochondria, and not the nucleus, 
so its affects on gene expression are relieved, basal ROS production returns, and homeostasis is 
maintained. (b) Loss of nuclear COQ7 (R28A mutant) in human cells or loss of CLK-1 in worms 
(clk-1(-)), that scavenge UQ from their bacterial diet, alters ROS metabolism leading to increased 
ROS levels, augments the UPRmt, and extends the lifespan of worms. (c) The augmented ROS 
levels, UPRmt and extended lifespan in clk-1(-) worms is suppressed by expression of a nuclear-
localised CLK-1 mutant (CLK-1nuc(+)) that acts as a rheostat to try and maintain mitochondrial 
homeostasis.    
 
Supplementary Figure 7: Uncropped western blots.  
 
Supplementary Table 1: Complete lifespan analysis of C. elegans strains. 
CLK-1nuc(+) expression partially rescues the increased lifespan observed in clk-1(-) worms while 
CLK-1wt completely rescues the longevity phenotype. The presented lifespan data includes the 
mean, maximum and 90th percentile lifespan with statistical analysis for each worm strain from 3 
independent experimental repeats. 
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Supplementary Table 2: ChIP array data 
 
 
Supplementary Table 3: Primer sequences for qPCR experiments. 
 
 
 
 
